Logo image of IB.MI

INIZIATIVE BRESCIANE-INBRE S (IB.MI) Stock Fundamental Analysis

BIT:IB - Euronext Milan - IT0005037905 - Common Stock - Currency: EUR

12.7  -0.5 (-3.79%)

Fundamental Rating

4

Taking everything into account, IB scores 4 out of 10 in our fundamental rating. IB was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. While IB is still in line with the averages on profitability rating, there are concerns on its financial health. IB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IB had positive earnings in the past year.
IB had a positive operating cash flow in the past year.
IB had positive earnings in 4 of the past 5 years.
In the past 5 years IB always reported a positive cash flow from operatings.
IB.MI Yearly Net Income VS EBIT VS OCF VS FCFIB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

IB has a Return On Assets (2.06%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 5.69%, IB is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
IB has a better Return On Invested Capital (5.24%) than 78.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IB is in line with the industry average of 4.87%.
The last Return On Invested Capital (5.24%) for IB is above the 3 year average (3.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.06%
ROE 5.69%
ROIC 5.24%
ROA(3y)1.19%
ROA(5y)1.68%
ROE(3y)3.36%
ROE(5y)4.35%
ROIC(3y)3.47%
ROIC(5y)3.87%
IB.MI Yearly ROA, ROE, ROICIB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

IB's Profit Margin of 16.75% is fine compared to the rest of the industry. IB outperforms 68.42% of its industry peers.
IB's Profit Margin has declined in the last couple of years.
The Operating Margin of IB (39.87%) is better than 84.21% of its industry peers.
In the last couple of years the Operating Margin of IB has declined.
With a decent Gross Margin value of 83.25%, IB is doing good in the industry, outperforming 68.42% of the companies in the same industry.
IB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 39.87%
PM (TTM) 16.75%
GM 83.25%
OM growth 3Y-2.55%
OM growth 5Y-4.85%
PM growth 3Y-5.29%
PM growth 5Y-5.99%
GM growth 3Y7.78%
GM growth 5Y-0.39%
IB.MI Yearly Profit, Operating, Gross MarginsIB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

IB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IB has about the same amount of shares outstanding.
The number of shares outstanding for IB has been increased compared to 5 years ago.
IB has a better debt/assets ratio than last year.
IB.MI Yearly Shares OutstandingIB.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
IB.MI Yearly Total Debt VS Total AssetsIB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

IB has an Altman-Z score of 0.59. This is a bad value and indicates that IB is not financially healthy and even has some risk of bankruptcy.
IB has a Altman-Z score of 0.59. This is in the lower half of the industry: IB underperforms 68.42% of its industry peers.
The Debt to FCF ratio of IB is 15.65, which is on the high side as it means it would take IB, 15.65 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.65, IB is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that IB has dependencies on debt financing.
IB has a Debt to Equity ratio of 1.02. This is in the lower half of the industry: IB underperforms 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.65
Altman-Z 0.59
ROIC/WACC0.9
WACC5.84%
IB.MI Yearly LT Debt VS Equity VS FCFIB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

IB has a Current Ratio of 0.52. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
IB's Current ratio of 0.52 is on the low side compared to the rest of the industry. IB is outperformed by 89.47% of its industry peers.
A Quick Ratio of 0.50 indicates that IB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.50, IB is doing worse than 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.5
IB.MI Yearly Current Assets VS Current LiabilitesIB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

IB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.18%, which is quite good.
The Earnings Per Share has been decreasing by -3.13% on average over the past years.
The Revenue has been growing slightly by 6.35% in the past year.
Measured over the past years, IB shows a quite strong growth in Revenue. The Revenue has been growing by 9.19% on average per year.
EPS 1Y (TTM)12.18%
EPS 3Y4.91%
EPS 5Y-3.13%
EPS Q2Q%1071.98%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y10.77%
Revenue growth 5Y9.19%
Sales Q2Q%-25.56%

3.2 Future

IB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.17% yearly.
The Revenue is expected to grow by 1.88% on average over the next years.
EPS Next Y19.15%
EPS Next 2Y14.85%
EPS Next 3Y7.17%
EPS Next 5YN/A
Revenue Next Year1.71%
Revenue Next 2Y1.16%
Revenue Next 3Y1.88%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IB.MI Yearly Revenue VS EstimatesIB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
IB.MI Yearly EPS VS EstimatesIB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

IB is valuated correctly with a Price/Earnings ratio of 15.68.
IB's Price/Earnings ratio is in line with the industry average.
IB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.73, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 11.01, the valuation of IB can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IB indicates a rather cheap valuation: IB is cheaper than 84.21% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.61. IB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.68
Fwd PE 11.01
IB.MI Price Earnings VS Forward Price EarningsIB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IB indicates a somewhat cheap valuation: IB is cheaper than 73.68% of the companies listed in the same industry.
IB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IB is cheaper than 78.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.49
EV/EBITDA 8.32
IB.MI Per share dataIB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

IB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IB may justify a higher PE ratio.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y14.85%
EPS Next 3Y7.17%

6

5. Dividend

5.1 Amount

IB has a Yearly Dividend Yield of 4.76%, which is a nice return.
Compared to an average industry Dividend Yield of 3.33, IB pays a better dividend. On top of this IB pays more dividend than 89.47% of the companies listed in the same industry.
IB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 4.76%

5.2 History

The dividend of IB decreases each year by -1.14%.
Dividend Growth(5Y)-1.14%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

IB pays out 82.40% of its income as dividend. This is not a sustainable payout ratio.
DP82.4%
EPS Next 2Y14.85%
EPS Next 3Y7.17%
IB.MI Yearly Income VS Free CF VS DividendIB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M
IB.MI Dividend Payout.IB.MI Dividend Payout, showing the Payout Ratio.IB.MI Dividend Payout.PayoutRetained Earnings

INIZIATIVE BRESCIANE-INBRE S

BIT:IB (8/11/2025, 7:00:00 PM)

12.7

-0.5 (-3.79%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.94M
Analysts84.44
Price Target17.85 (40.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.76%
Yearly Dividend0.67
Dividend Growth(5Y)-1.14%
DP82.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.68
Fwd PE 11.01
P/S 2.71
P/FCF 10.49
P/OCF 4.16
P/B 0.92
P/tB 2.53
EV/EBITDA 8.32
EPS(TTM)0.81
EY6.38%
EPS(NY)1.15
Fwd EY9.08%
FCF(TTM)1.21
FCFY9.54%
OCF(TTM)3.05
OCFY24.03%
SpS4.69
BVpS13.8
TBVpS5.01
PEG (NY)0.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.06%
ROE 5.69%
ROCE 5.98%
ROIC 5.24%
ROICexc 5.4%
ROICexgc 7.59%
OM 39.87%
PM (TTM) 16.75%
GM 83.25%
FCFM 25.82%
ROA(3y)1.19%
ROA(5y)1.68%
ROE(3y)3.36%
ROE(5y)4.35%
ROIC(3y)3.47%
ROIC(5y)3.87%
ROICexc(3y)3.65%
ROICexc(5y)4.29%
ROICexgc(3y)5.12%
ROICexgc(5y)6.36%
ROCE(3y)3.95%
ROCE(5y)4.42%
ROICexcg growth 3Y3.16%
ROICexcg growth 5Y-17.86%
ROICexc growth 3Y3.64%
ROICexc growth 5Y-9.34%
OM growth 3Y-2.55%
OM growth 5Y-4.85%
PM growth 3Y-5.29%
PM growth 5Y-5.99%
GM growth 3Y7.78%
GM growth 5Y-0.39%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.65
Debt/EBITDA 3.82
Cap/Depr 100.84%
Cap/Sales 39.23%
Interest Coverage 250
Cash Conversion 82.58%
Profit Quality 154.12%
Current Ratio 0.52
Quick Ratio 0.5
Altman-Z 0.59
F-Score6
WACC5.84%
ROIC/WACC0.9
Cap/Depr(3y)172.61%
Cap/Depr(5y)214.84%
Cap/Sales(3y)78.23%
Cap/Sales(5y)96.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.18%
EPS 3Y4.91%
EPS 5Y-3.13%
EPS Q2Q%1071.98%
EPS Next Y19.15%
EPS Next 2Y14.85%
EPS Next 3Y7.17%
EPS Next 5YN/A
Revenue 1Y (TTM)6.35%
Revenue growth 3Y10.77%
Revenue growth 5Y9.19%
Sales Q2Q%-25.56%
Revenue Next Year1.71%
Revenue Next 2Y1.16%
Revenue Next 3Y1.88%
Revenue Next 5YN/A
EBIT growth 1Y24.26%
EBIT growth 3Y7.95%
EBIT growth 5Y3.9%
EBIT Next Year115.88%
EBIT Next 3Y30.26%
EBIT Next 5YN/A
FCF growth 1Y208.03%
FCF growth 3YN/A
FCF growth 5Y-10.18%
OCF growth 1Y49.9%
OCF growth 3Y22.64%
OCF growth 5Y6.19%